TY  - GEN
AU  - Heskamp,Sandra
AU  - Boerman,Otto C
AU  - Molkenboer-Kuenen,Janneke D M
AU  - Sweep,Fred C G J
AU  - Geurts-Moespot,Anneke
AU  - Engelhardt,Mallory S
AU  - van der Graaf,Winette T A
AU  - Oyen,Wim J G
AU  - van Laarhoven,Hanneke W M
TI  - Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression
SN  - 1543-8392
PY  - 2015///0714
KW  - Animals
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cetuximab
KW  - Enzyme-Linked Immunosorbent Assay
KW  - ErbB Receptors
KW  - metabolism
KW  - Female
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Molecular Targeted Therapy
KW  - Multimodal Imaging
KW  - Tumor Cells, Cultured
KW  - Vascular Endothelial Growth Factor A
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1021/mp500460g
ER  -